ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 34

Dichotomous Responses Of Human Systemic Lupus Erythematosus B Cell Subsets To B Cell Receptor Stimulation

Franziska Matzkies1, Anthony DeFranco2, Andrew J. Gross3, Maria Dall'era4 and Michelle Hermiston5, 1Medicine- Rheumatology, University of California, San Francisco, San Francisco, CA, 2Microbiology & Immunology, University of California, San Francisco, San Francisco, CA, 3Medicine, University of California, San Francisco, San Francisco, CA, 4Medicine/Rheumatology, University of California, San Francisco, San Francisco, CA, 5Pediatrics, Hematology/Oncology, University of California, San Francisco, San Francisco, CA

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: B cells, mTor and signal transduction, SLE

  • Tweet
  • Email
  • Print
Session Information

Title: B cell Function and Targeting in Systemic Lupus Erythematosus

Session Type: Abstract Submissions (ACR)

Background/Purpose:

Autoantibody production is a hallmark of Systemic Lupus Erythematosus (SLE), supporting a central role for B cells in disease pathogenesis. Prior studies have demonstrated augmented B cell receptor (BCR) signaling in a subset of SLE patients relative to healthy controls (HC). Both B cell intrinsic factors such as aberrant signal network wiring and B cell extrinsic factors such as excessive cytokines have been implicated in loss of B cell tolerance and B cell hyperactivity. However, previous studies have generally examined these parameters in total peripheral blood B cells rather than in well defined subpopulations. This is an important distinction because BCR signaling in mature naive B-cells leads to proliferation and survival, while these same signals lead to receptor editing, depletion or anergy in immature cells. We hypothesize that dysregulation of these signaling networks could contribute to SLE pathogenesis.

Methods:

Peripheral blood was obtained from 12 patients satisfying ACR SLE criteria and 12 HC that lacked a family history of autoimmune disease. To minimize confounding influences of cytokines, patients had low disease activity (SLEADI<5). B cells were enriched with RosettespTM and ficoll, rested at 37°C for 1 hr, stimulated with 10 µg/ml (low dose) or 50 µg/ml (high dose) of F(ab’)2 goat anti-human IgM or phorbal 12-myristate 13-acetae (PMA), immediately fixed, and processed for flow cytometry. Phosphorylation of intracellular signaling proteins (pSyk, pPLCg, pERK, pAKT, pS6) in transitional (CD20+CD27–CD24HiCD38Hi) and naïve (CD20+CD27–CD24IntCD38Int) B cells was measured using FlowJo 8.8.7 and Cytobank software.

Results:

The basal phosphorylation states of Syk, ERK, PLCg, and S6 were increased in both transitional and naïve B cells of SLE patients relative to HCs. Upon BCR ligation, both transitional and naïve SLE B cells demonstrated augmented phosphorylation of SYK, ERK, and PLCg relative to HC. Surprisingly, these same patients displayed hypo-phosphorylation of S6 in response to the same stimuli. Interestingly, hypo-activation of S6 was observed in mature naïve but not transitional B cells. The response to stimulation with PMA, which bypasses proximal signaling machinery, was equivalent in SLE and HC B cell subsets, indicating that the difference in signaling was upstream of S6.

Conclusion:

We find that both transitional and naïve B cells obtained from SLE patients with well-controlled disease have increased activation of the MAPK pathway in the basal state and in response to BCR stimulation. Phosphorylation of S6, which is downstream of the PI3K/AKT/mTOR pathway, is also elevated in the basal state in SLE B cell subsets, but surprisingly hypophosphorylated in naïve mature but not transitional B cells in response to BCR ligation in these same patients. While S6 is a target of the PI3K pathways after BCR ligation, it also receives inputs through growth hormone and cytokine receptors as well as the mTOR complex, which plays a key role in sensing energy and nutritional levels. Current investigations are under way to identify the mechanisms mediating these observations and their relation to SLE pathogenesis.


Disclosure:

F. Matzkies,
None;

A. DeFranco,
None;

A. J. Gross,
None;

M. Dall’era,
None;

M. Hermiston,
None.

  • Tweet
  • Email
  • Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/dichotomous-responses-of-human-systemic-lupus-erythematosus-b-cell-subsets-to-b-cell-receptor-stimulation/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology